EFL
TMO icon

ERn Financial LLC’s Thermo Fisher Scientific TMO Stock Holding History

ERn Financial LLC’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,663
Closed -$827K – 179
2025
Q1 		$827K Sell
1,663
-210
-11% -$114K 0.13% 110
2024
Q4 		$975K Buy
1,873
+50
+3% +$27.5K 0.15% 100
2024
Q3 		$1.13M Sell
1,823
-28
-2% -$16.6K 0.17% 90
2024
Q2 		$1.02M Buy
1,851
+32
+2% +$18.3K 0.17% 92
2024
Q1 		$1.06M Buy
1,819
+29
+2% +$16.3K 0.18% 90
2023
Q4 		$975K Buy
1,790
+62
+4% +$30K 0.18% 89
2023
Q3 		$875K Buy
1,728
+163
+10% +$86.9K 0.19% 92
2023
Q2 		$817K Buy
1,565
+25
+2% +$13.5K 0.17% 98
2023
Q1 		$887K Buy
1,540
+29
+2% +$16.3K 0.2% 89
2022
Q4 		$832K Buy
1,511
+100
+7% +$53K 0.19% 91
2022
Q3 		$715K Sell
1,411
-33
-2% -$18.5K 0.18% 88
2022
Q2 		$785K Buy
1,444
+549
+61% +$302K 0.19% 87
2022
Q1 		$529K Buy
+895
New +$514K 0.12% 103

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

ERn Financial LLC's TMO Position: Q2 2025 in Review

ERn Financial LLC sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 1,663 shares — an estimated $827K sold.

ERn Financial LLC first reported a position in TMO in Q1 2022 and held it in 13 quarters. The position peaked at $1.13M in Q3 2024. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • ERn Financial LLC reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • ERn Financial LLC sold 1,663 Thermo Fisher Scientific shares in Q2 2025, an estimated $827K.
  • ERn Financial LLC first reported a position in Thermo Fisher Scientific in Q1 2022 and held it in 13 quarters.
  • ERn Financial LLC's Thermo Fisher Scientific position peaked at $1.13M in Q3 2024.
  • 2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on ERn Financial LLC's 13F filing for Q2 2025, filed 17 Jul 2025.